HCA Healthcare Inc (NYSE:HCA) SVP Sandra L. Morgan sold 3,698 shares of HCA Healthcare stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $96.91, for a total transaction of $358,373.18. Following the completion of the transaction, the senior vice president now directly owns 5,410 shares of the company’s stock, valued at approximately $524,283.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of HCA Healthcare Inc (NYSE HCA) traded down $1.09 during trading on Thursday, reaching $97.31. 911,465 shares of the company’s stock traded hands, compared to its average volume of 2,487,484. The company has a current ratio of 1.62, a quick ratio of 1.36 and a debt-to-equity ratio of -6.58. HCA Healthcare Inc has a 12-month low of $71.18 and a 12-month high of $106.84. The company has a market capitalization of $35,240.00, a PE ratio of 16.38, a PEG ratio of 0.99 and a beta of 0.48.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 30th. The company reported $2.12 EPS for the quarter, topping the consensus estimate of $1.87 by $0.25. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The firm had revenue of $11.56 billion for the quarter, compared to analysts’ expectations of $11.19 billion. During the same period in the previous year, the business earned $1.80 earnings per share. HCA Healthcare’s revenue for the quarter was up 8.7% compared to the same quarter last year. equities research analysts anticipate that HCA Healthcare Inc will post 8.71 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Shareholders of record on Thursday, March 1st will be issued a dividend of $0.35 per share. The ex-dividend date of this dividend is Wednesday, February 28th. This represents a $1.40 annualized dividend and a yield of 1.44%.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Argent Capital Management LLC raised its holdings in HCA Healthcare by 1.2% during the 2nd quarter. Argent Capital Management LLC now owns 4,370 shares of the company’s stock worth $381,000 after buying an additional 50 shares during the period. Advisor Partners LLC grew its stake in HCA Healthcare by 13.5% during the 4th quarter. Advisor Partners LLC now owns 4,442 shares of the company’s stock valued at $413,000 after acquiring an additional 528 shares in the last quarter. Ladenburg Thalmann Financial Services Inc. grew its stake in HCA Healthcare by 8.3% during the 3rd quarter. Ladenburg Thalmann Financial Services Inc. now owns 9,502 shares of the company’s stock valued at $756,000 after acquiring an additional 729 shares in the last quarter. Amalgamated Bank grew its stake in HCA Healthcare by 2.3% during the 3rd quarter. Amalgamated Bank now owns 33,983 shares of the company’s stock valued at $2,705,000 after acquiring an additional 754 shares in the last quarter. Finally, Mutual of America Capital Management LLC grew its stake in HCA Healthcare by 2.2% during the 3rd quarter. Mutual of America Capital Management LLC now owns 35,732 shares of the company’s stock valued at $2,844,000 after acquiring an additional 761 shares in the last quarter. Hedge funds and other institutional investors own 74.89% of the company’s stock.

HCA has been the subject of several analyst reports. Credit Suisse Group reissued an “outperform” rating and set a $25.00 price target on shares of HCA Healthcare in a report on Tuesday, December 26th. Robert W. Baird set a $104.00 price target on shares of HCA Healthcare and gave the company a “buy” rating in a report on Friday, January 12th. Raymond James Financial downgraded shares of HCA Healthcare from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, October 18th. Morgan Stanley downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 price target for the company. in a report on Wednesday, December 20th. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $95.00 price target on shares of HCA Healthcare in a report on Friday, October 13th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $103.65.

ILLEGAL ACTIVITY WARNING: This report was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.dailypolitical.com/2018/02/08/sandra-l-morgan-sells-3698-shares-of-hca-healthcare-inc-hca-stock.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.